Other clinicopathological features, such as sex, age, depth of invasion, lymph node metastasis or TNM stage, did not exhibit any association with KRAS mutations, which is consistent with a recent report of Chinese patients22. Here, KRAS is linked to metastatic malignant neoplasm in the lymph nodes.